DE3152175T1 - Platinum(ii)complexes and antineoplastic agents containing same as effective ingredients - Google Patents

Platinum(ii)complexes and antineoplastic agents containing same as effective ingredients

Info

Publication number
DE3152175T1
DE3152175T1 DE813152175T DE3152175T DE3152175T1 DE 3152175 T1 DE3152175 T1 DE 3152175T1 DE 813152175 T DE813152175 T DE 813152175T DE 3152175 T DE3152175 T DE 3152175T DE 3152175 T1 DE3152175 T1 DE 3152175T1
Authority
DE
Germany
Prior art keywords
hcoh
platinum
coo
meaning
complex according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE813152175T
Other languages
English (en)
Other versions
DE3152175C2 (de
Inventor
Y Kidani
M Noji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Chemical Co Ltd
Original Assignee
Otsuka Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Chemical Co Ltd filed Critical Otsuka Chemical Co Ltd
Publication of DE3152175T1 publication Critical patent/DE3152175T1/de
Application granted granted Critical
Publication of DE3152175C2 publication Critical patent/DE3152175C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/10—Polyhydroxy carboxylic acids
    • C07C59/105—Polyhydroxy carboxylic acids having five or more carbon atoms, e.g. aldonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Description

Leerseite

Claims (1)

  1. 52 1
    10 ' Pat ent ansprüche.
    Ά. Platin(II)-komplex, dargestellt durch die allgemeine Formel ' ·
    J>Pt(II)'
    20 worin -B-B- die Bedeutung hat von
    R1C o) -NH9 1 I
    R1-CH-NH
    ,-NH «Ι« i {?2^ \ 2 m λ \ R1-CH-NH2
    25 . " Ζ" ' ' ■
    • ' (worin R^ und· Ro gleich oder verschieden sind und jedes Wasserstoff eine Alkylgruppe oder eine Arylgruppe ist, und n, m und X O sind oder eine ganze Zahl von Λ bis' 3), mindestens eines von A. und Ap
    30 die Bedeutung hat von
    COO
    ' HCOH
    HOCH
    35 HCOH
    HCOH 1 CH
    λί
    und das andere die Bedeutung hat von
    r- COO"*
    I
    HCOH
    HOCH HCOH HCOH CH2OH
    Cl",.Bt",. I", P", XCH2COO" (worin X ein Halogenatom ist), NO-,", SO/"", HpPO/~ oder HpO, oder zusammengenommen, A. und Ap einen Ring zusammen mit Pt(II) bilden können, wobei im letzteren Falle -A^-Ap- die Bedeutung hat von
    coo-
    HCOH
    HOCH I
    HCOH
    HCOH I
    CH2OH
    2. Platin(II)-komplex nach Anspruch Λ , worin mindestens-
    eines von Ax, und Ap in der allgemeinen Formel die t Bedeutung hat von
    COO"
    HC(
    HCOH
    I HOCH
    HCOH
    HCOH I
    CH2OH
    \.:Ό* Ü\.": ■" r*/-'.::3i'521
    5. Platin(II)-komplex nach Anspruch 1 oder 2, worin -B-B- 1^-Diaminocyclohexan ist.
    4-, Piatin(II)-komplex nach Anspruch 3, worin das 1,2-Diaminocyclohexan in der cis-Form, trans-d-Form oder trans-X-Fornr ist.
    !0 5· Platin(II)-komplex nach Anspruch 1 oder 2, worin ■ -B-B- in der allgemeinen Formel 1-Amino~2-aminomethylcyclohexan ist.
    6. Platin(II)-komplex nach Anspruch 5, worin das 1-
    ■ Amino-2-aminomethylcyclohexan die cis-d-Porm, cis-£- Form, trans-d-Porm oder trans-ü-Form ist.
    . ?. Platin(II)-komplex nach Anspruch 1 oder 2, worin -B-B- in der allgemeinen Formel Λ,2-Diphenyläthylendiamin ist.
    8. Platin(II)-komplex nach Anspruch 7i worin das 1,2- : Diphenylathylendiamin die meso-Porm, trans-d-Porm oder trans-j£-Form ist.
    9· Platin(II)-komplex nach Anspruch 1 oder 2, worin -B-B- in der allgemeinen Formel 1~Phenyläthylendiamin ist.
    10. Antineoplastisch.es Mittel, enthaltend einen Platin-. (Il)-komplex, dargestellt durch die allgemeine Formel :
    B
    35
    vr Ig
    worin -B-B- die Bedeutung hat von
    H |(CH2}n-NH2
    oder
    R,r-CH-NHO )
    R1-CH-NH2
    10
    15
    20
    25
    30
    35
    (worin R. und R2 gleich oder verschieden sind und ■ jedes Wasserstoff eine Alkylgruppe oder eine Arylgruppe ist, und n, m und Jl 0 oder eine ganze Zahl von 1 "bis 3 sind), mindestens eines von A^ und A2 die Bedeutung hat von
    COO" HCOH
    HOCH . I HCOH
    HCOH I
    und das andere die Bedeutung hat von
    COO" HCOH HOCH HCOH HCOH
    CH2OH
    Cr", Br"
    XCH2COO
    (worin X ein Halogenatom ist), NO,"", SO^ , H2PO^" oder H2O, oder zusammengenommen A. und A2 einen Ring zusammen mit Pt(II) bilden können, wobei im letzteren Falle -A^-A2- die
    Bedeutung hat von
    coo-
    HCOH
    HOCH
    HCOH
    I HCOH
    CH2OH
DE813152175T 1980-07-05 1981-07-04 Platinum(ii)complexes and antineoplastic agents containing same as effective ingredients Granted DE3152175T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9206680A JPS5716895A (en) 1980-07-05 1980-07-05 Platinum 2 complex and antitumor agent containing the same as active principle
PCT/JP1981/000154 WO1982000145A1 (en) 1980-07-05 1981-07-04 Platinum(ii)complexes and antineoplastic agents containing same as effective ingredients

Publications (2)

Publication Number Publication Date
DE3152175T1 true DE3152175T1 (de) 1982-11-18
DE3152175C2 DE3152175C2 (de) 1989-11-30

Family

ID=14044093

Family Applications (1)

Application Number Title Priority Date Filing Date
DE813152175T Granted DE3152175T1 (de) 1980-07-05 1981-07-04 Platinum(ii)complexes and antineoplastic agents containing same as effective ingredients

Country Status (5)

Country Link
US (1) US4477387A (de)
EP (1) EP0055300A4 (de)
JP (1) JPS5716895A (de)
DE (1) DE3152175T1 (de)
WO (1) WO1982000145A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5921697A (ja) * 1982-06-24 1984-02-03 Yoshinori Kitani 新規な白金錯体
JPS59112995A (ja) * 1982-12-21 1984-06-29 Shionogi & Co Ltd 新規グリコ−ル酸白金錯体
US4598091A (en) * 1983-02-18 1986-07-01 Degussa Aktiengesellschaft (1,2-diphenyl)-ethylenediamine)-platinum (II) complex compounds
DE3405611A1 (de) * 1983-02-18 1984-08-23 Degussa Ag, 6000 Frankfurt (1,2-diphenyl-ethylendiamin)-platin(ii)-komplexverbindungen
EP0130482B1 (de) * 1983-06-20 1988-12-28 Research Corporation Diaminocyclohexan-Platin-Komplexe, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
US4661516A (en) * 1983-06-20 1987-04-28 Research Corporation Diaminocyclohexane platinum complexes
US4758588A (en) * 1983-06-20 1988-07-19 Research Corporation Technologies Diaminocyclohexane platinum complexes
DE3477788D1 (en) * 1983-08-05 1989-05-24 Yoshinori Kidani Cytostatic platinum complexes
JPS6087295A (ja) * 1983-10-19 1985-05-16 Nippon Kayaku Co Ltd 新規白金錯体
US4562275A (en) * 1984-03-23 1985-12-31 Bristol-Myers Co. Antitumor platinum complexes
US4665210A (en) * 1984-12-17 1987-05-12 American Cyanamid Company Platinum complexes of aliphatic tricarboxylic acids
ZA86704B (en) * 1985-02-23 1986-10-29 Asta Werke Ag Chem Fab Tumor retarding(1-benzyl-ethylenediamine9-platin(ii)-complexes
JPS6296A (ja) * 1985-03-06 1987-01-06 Sumitomo Pharmaceut Co Ltd 脂溶性白金（２）錯体
EP0207202A1 (de) * 1985-07-04 1987-01-07 Yoshinori Kidani Antitumor Platinkomplexe
US4567285A (en) * 1985-07-10 1986-01-28 Yoshinori Kidani Complex compounds of platinum
JPS6345290A (ja) * 1985-08-27 1988-02-26 Nippon Kayaku Co Ltd 新規白金錯体
US4737589A (en) * 1985-08-27 1988-04-12 Nippon Kayaku Kabushiki Kaisha Platinum Complexes
JPS63203692A (ja) * 1987-02-19 1988-08-23 Nippon Kayaku Co Ltd 新規白金錯体
US4904809A (en) * 1987-09-25 1990-02-27 Ss Pharmaceutical Co., Ltd. Platinum complex
DE3843571A1 (de) * 1988-01-09 1989-07-20 Asta Pharma Ag 1,2-bis(aminomethyl)cyclobutan-platin-komplexe
US5049686A (en) * 1989-09-13 1991-09-17 Warner-Lambert Company Novel large-ring diamine platinum(II) and platinum(IV) chelates
CZ300665B6 (cs) * 2007-01-22 2009-07-15 Pliva-Lachema A. S. Sterilní kapalná farmaceutická kompozice a zpusob její výroby
CZ300664B6 (cs) * 2007-01-22 2009-07-15 Pliva-Lachema A. S. Sterilní kapalná farmaceutická kompozice a zpusob její výroby
WO2015070177A2 (en) * 2013-11-11 2015-05-14 Collaborative Medicinal Development, Llc Metal complexes and methods of treatment

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH588505A5 (de) * 1972-06-08 1977-06-15 Research Corp
US4115418A (en) * 1976-09-02 1978-09-19 Government Of The United States Of America 1,2-diaminocyclohexane platinum (ii) complexes having antineoplastic activity
JPS6041077B2 (ja) * 1976-09-06 1985-09-13 喜徳 喜谷 １，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
JPS5829957B2 (ja) * 1977-09-12 1983-06-25 喜徳 喜谷 新規な白金錯体
US4203912A (en) * 1977-10-19 1980-05-20 Johnson, Matthey & Co., Limited Compositions containing platinum
SE7903361L (sv) * 1978-04-20 1979-10-21 Johnson Matthey Co Ltd Kompositioner innehallande platina
NL7807334A (nl) * 1978-07-06 1980-01-08 Tno Platina-diaminecomplexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een genees- middel met toepassing van een dergelijk platina-dia- minecomplex voor de behandeling van kanker, alsmede al- dus verkregen gevormd geneesmiddel.
JPS6034958B2 (ja) * 1978-09-02 1985-08-12 喜徳 喜谷 新規白金錯体
US4271085A (en) * 1979-06-20 1981-06-02 Engelhard Minerals & Chemicals Corporation Cis-platinum (II) amine lactate complexes
JPS56154493A (en) * 1980-04-30 1981-11-30 Shionogi & Co Ltd Novel platinum complex

Also Published As

Publication number Publication date
WO1982000145A1 (en) 1982-01-21
JPS5716895A (en) 1982-01-28
DE3152175C2 (de) 1989-11-30
EP0055300A4 (de) 1982-10-14
US4477387A (en) 1984-10-16
EP0055300A1 (de) 1982-07-07

Similar Documents

Publication Publication Date Title
DE3152175T1 (de) Platinum(ii)complexes and antineoplastic agents containing same as effective ingredients
Cotton et al. Some reactions of the octahalodirhenate (III) ions. II. Preparation and properties of tetracarboxylato compounds
DE2916145A1 (de) Stoffzusammensetzung mit platin
DE273229T1 (de) Herstellung von aminoalanen.
Hidaka et al. Circular dichroism of coordination compounds. II. Some metal complexes of 2, 2'-dipyridyl and 1, 10-phenanthroline
Doyle et al. Synthesis of. beta.-diketonate chelates of the bis (cyclopentadienyl) titanium (IV) moiety: infrared and proton magnetic resonance spectra
Nelson et al. Seven-coordination in some mononuclear and binuclear iron (III) complexes containing a pentadentate macrocyclic ring
Keller Jr et al. A study by Raman Spectroscopy of complex ions formed by tantalum (V) in the system Ta (V)-HF-NH4F-H2O
Magnuson et al. Mixed oxidation states in osmium ammine dinitrogen complexes
Walton Coordination compounds of thallium (III). III. Vibrational spectra of several anionic and neutral complexes of thallium (III) chloride and iodide and the nature of these species in the solid state and in polar solvents
GB1487416A (en) Phosphono-methyl compounds and their use
GB2013207A (en) Hydrosilylation Catalysts
DE2961067D1 (en) Process for preparing polycondensation products from ketones and aldehydes with the help of phase transfer catalysts
Karayannis et al. Uranium (IV) and thorium (IV) Tetrakis-(dialkoxyphosphato) and Tetrakis-(alkoxy alkylphosphonato) Polynuclear complexes
Bautista et al. NMR studies of the complexes trans-[M (η2-H2)(H)(Ph2PCH2CH2PEt2) 2] X (M= Fe, X= BPh4; M= Os, X= BF4): evidence for unexpected shortening of the HH bond
Morimoto et al. Photochemistry of the copper (II)-malonate system. Sensitized reaction
DE29912327U1 (de) Mittel zum Färben und Tönen keratinischer Fasern
DE1695641A1 (de) Neue Pyrrolinderivate und Verfahren zu ihrer Herstellung
Wilkins et al. Kinetic evidence pertaining to the structure of the cobalt (II)-EDTA complex in aqueous solution
Singh et al. Mono-, Bi-& Tri-Nuclear Dioxouranium (VI) Complexes with Oximes & Polydentate Schiff Bases
Evans et al. Complexes of a Water-soluble tridentate schiff base Ligand with a Number of “Hard” Metal Ions
Katzin et al. Some New Pyridine Compounds of Cobalt (II) Salts
Bok et al. Synergism in the Solvent Extraction of Tetravalent Metal Ions. A Study of the Formation of the Synergistic Adducts
DE20104441U1 (de) Haarfärbemittel
Vaughn et al. Fluoro-containing complexes of chromium (III). IV. Reactions of trans-fluoroaquobis (ethylenediamine)-chromium (III) perchlorate monohydrate with ammonium chloride and ammonium bromide

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8125 Change of the main classification

Ipc: C07C 87/00

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee